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Tuesday, February 5, 2013 443aevidence for protein conformational changes upon ATP or caffeine binding.
We observed a similar binding affinity of the expressed RyR2 central domain
for both compounds, with an EC50 ~100mM. The presence of the individual
mutations made no apparent difference to the EC50. However, there was an in-
creased initial fluorescence value observed for each of the mutant constructs
compared to WT. Analysis of the central domain sequence revealed homology
with conserved motifs typical of P-loop kinases. Interestingly, many of the
CPVT mutations present in this region are coincident with sites corresponding
to the Walker A, Walker B and LID motifs in ATP binding proteins.
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The ryanodine receptor (RyR) is an intracellular ion channel with an important
role in depolarization-induced Ca2þ release in excitable cells. For the skeletal
muscle isoform RyR1, the open and closed conformations were determined at
10 A˚ resolution by cryoEM, and their structural analysis suggest that RyR1,
with four inner helices forming a helical bundle, has a similar gating mechanism
to that of Kþ channels. Upon gating, RyR1’s large cytoplasmic domain also un-
dergoes conformational changes, underlying a long-range communication path-
way between the ion gate and effectors bound more than 130 A˚ away. One of
such effectors is the FK506-binding protein of 12 kDa (FKBP12), which we lo-
calized at the interface of the ‘‘handle’’ and the ‘‘clamp’’ domains of RyR1. At
the functional level, and under activating [Ca2þ] concentrations, single channel
experiments with purifiedRyR1 show that FKBP12 increasedRyR1’s Po and re-
distributed its subconductance states towards higher conductance levels. At the
structural level, we found that under sub-activating [Ca2þ] concentrations and in
the absence of FKBP12, RyR1’s cytoplasmic domain appears to be a structural
intermediate of the well-defined open- and closed-state RyR1-FKBP12 confor-
mations, whereas the inner helices remain in the closed conformation. Overall,
our studies suggest that while [Ca2þ] exerts a dominant effect in RyR1’s gating,
FKBP12 changes the energy landscape of RyR1’s structural transitions.
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Activation of the skeletal muscle ryanodine receptor (RyR1) complex results in
the rapid release of Ca2þ from the sarcoplasmic reticulum and muscle contrac-
tion. Dissociation of the small FK506-binding protein 12 subunit (FKBP12) in-
creases RyR1 activity and leads to the impairment of muscle function. The 1,4-
benzothiazepine derivative JTV519, and more specific derivative S107
(2,3,4,5,-tetrahydro-7-methoxy-4-methyl-1,4-benzothiazepine), are thought to
improve skeletal muscle function by stabilizing the RyR1-FKBP12 complex.
Here, we report that SR vesicles enriched in RyR1 bound a large number of
S107 molecules with micromolar affinity. The effects of S107 and FKBP12
on RyR1 were examined under conditions that altered the redox state of
RyR1. In SR vesicles, S107 increased FKBP12 binding to RyR1 in presence
of reduced glutathione and the NO-donor NOC12. S107 was without effect
in the presence of oxidized glutathione. Addition of 0.15 mM FKBP12 to SR
vesicles prevented FKBP12 dissociation, whereas in the presence of oxidized
glutathione and NOC12 FKBP12 dissociation was observed in skeletal muscle
homogenates that contained 0.43 mM myoplasmic FKBP12, and this dissocia-
tion was attenuated by S107. In single channel measurements, pretreatment of
FKBP12-depleted RyR1s with S107 in the absence and presence of NOC12
augmented the FKBP12-mediated decrease in channel activity. The data sug-
gest that S107 can reverse the harmful effects of redox active species on SR
Ca2þ release in skeletal muscle.
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We have recently demonstrated, both at the single-channel level and in iso-
lated cardiac cells (Galfre et al., (2011) PLoS ONE, 7, Issue 2, e31956), that
the cardiac RyR (RyR2) is activated by FKBP12 and that this effect is reg-
ulated by the antagonistic action of FKBP12.6. We now investigate whether
FKBPs can also activate skeletal RyR (RyR1) and examined the relationshipbetween FKBP structure and the ability to activate RyR1 and RyR2. We
generated a mutant FKBP12 (FKBP12E31Q/D32N/W59F) where the amino acids
Glu31, Asp32 and Trp59 were mutated to the respective residues found in
FKBP12.6 (Gln, Asn and Phe). The effects of the wild type and mutant
FKBP12E31Q/D32N/W59F proteins on the single-channel gating of RyR1 and
RyR2 were then compared. Our results show that FKBP12.6 promotes acti-
vation of RyR1 whereas FKBP12 promotes activation of RyR2. The FKBP12
mutant, FKBP12E31Q/D32N/W59F did not alter RyR2 Po (n=5) but caused sig-
nificant activation of RyR1; for example Po was 0.02150.008 before and
0.11050.026 after addition of cytosolic 1 mM FKBP12E31Q/D32N/W59F
(SEM; n=7; **p<0.01)). The FKBP12 mutant, therefore, no longer behaves
like FKBP12 but instead mimics the actions of FKBP12.6 on both RyR iso-
forms. In conclusion, we demonstrate that FKBP12 and FKBP12.6 specifi-
cally activate RyR2 and RyR1, respectively. Our results also suggest that
the ability of FKBP12 and FKBP12.6 to activate RyR channels is contained
within just three amino acid residues of FKBP12 (Glu31, Asp32 and Trp59)
and the corresponding residues in FKBP12.6 (Gln31, Asn32 and Phe59). These
results shed new light on the interactions of FKBPs with RyR channels and
will be important for understanding the dual role of FKBP12 and FKBP12.6
as regulators of sarcoplasmic reticulum Ca2þ-release in cardiac and skeletal
muscle.
Supported by the BHF
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The type 1 ryanodine receptor (RyR1) is an intracellular calcium channel that
plays an integral role in skeletal muscle excitation-contraction coupling. The
functional properties of this protein are regulated by numerous associated pro-
teins, including FKBP12, a skeletal muscle protein that stabilizes full RyR1
channel gating. While the binding site of FKBP12 was originally identified at
position 2458 of RyR1, subsequent reports have localized additional binding
determinants within the N-terminal domain of RyR1. In this study, we used
fluorescence resonance energy transfer (FRET) to determine the orientation
and proximity of FKBP relative to sites either within the N-terminal domain
or near amino acid position 2458. We utilized the cardiac muscle isoform
FKBP12.6 (which binds to RyR1 at the same site as FKBP12 but with higher
affinity and stability) labeled with the FRET donor Alexa Fluor 488 at either
position 14, 44, 49, or 85. Specific binding of each labeled FKBP to RyR was
confirmed in permeabilized HEK-293T cells expressing wtRyR1. Weak energy
transfer was observed from FKBP12.6 to the FRET acceptor Cy3NTA, which
was targeted to poly-histidine ‘‘tags’’ placed in the N-terminal domain. This re-
sult suggested that the acceptors were not proximal (~90A˚ away) to FKBP12.6
bound to RyR1. Next, we measured FRET from FKBP12.6 to Cy3NTA targeted
to positions 2157, 2341, 2502 and 2777 of RyR1. FKBP12.6 binding to con-
structs containing His-tags at positions 2157 and 2502 was significantly reduced
relative to binding to wtRyR1. In contrast, we detected strong and weak FRET
efficiencies from FKBP12.6 to positions 2341 and 2777, respectively. These
data suggest that FKBP12.6 binds near amino acid position 2341 but far from
the N-terminal domain of RyR1. Supported by NIH grant R01AR059124 (to
JDF and TG) and R01HL092097 (to RLC).
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Type 1 ryanodine receptor (RyR1) is a key protein involved in the regulation of
the intracellular Ca2þ concentration in skeletal muscle cells, playing a crucial
role in muscle contraction by releasing Ca2þ from the sarcoplasmic reticulum
after plasma membrane depolarization. Dysregulation of calcium signals due to
defects in RyR1 have been associated with a wide range of primary neuromus-
cular disorders, including Malignant Hyperthermia Susceptibility and a number
of congenital myopathies including Core Myopathies, some forms of Centronu-
clear myopathy and congenital fiber type disproportion. Though RyR1 is pref-
erentially expressed in skeletal muscles recent data has shown that it is also
expressed in some areas of the central nervous system, in some cells of the im-
mune system (B-lymphocytes and dendritic cells) and in smooth muscle cells.
Thus mutations in RYR1 (the gene encoding RyR1) may lead to alterations of
Ca2þ homeostasis not only in skeletal muscle, but also in other tissues express-
ing this intracellular calcium release channel.
444a Tuesday, February 5, 2013Using an animal model knocked in for the RYR1Y522S mutation we observed
that bleeding times were increased by more than two fold in heterozygous
mice compared to their wild type littermates, with no differences in platelet
numbers nor aggregation characteristics between heterozygous RYR1Y522S car-
riers and control littermates. Bleeding abnormalities have also been seen in
some patients with dominant RYR1mutations; as part of a comprehensive study
we investigated in detail RyR1 expression in smooth muscle cells isolated from
different tissues and if there is a causal link between RYR1 mutations and pro-
longed bleeding times.
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Ryanodine receptors (RyRs) form a class of intracellular calcium release chan-
nels in various excitable tissues and cells such as muscles and neurons. They are
themajor cellularmediators of the release of calcium ions from the sarcoplasmic
reticulum, an essential step in muscle excitation-contraction coupling. Several
crystal structures of skeletal muscle RyR1 peptide fragments have been solved,
but these cover less than 15% of the full-length RyR1 sequence. In the present
study, we obtain pseudo-atomic models for RyR fragments, consisting of resi-
dues 850-1,056 in rabbit RyR1 or residues 861-1,067 in mouse RyR2, by com-
bining modeling techniques with sub-nanometer resolution cryo-electron
microscopy (cryo-EM)maps. These fragments dock into a domain that connects
the central vestibule and corner clamp region of RyR, with a good match be-
tween the secondary structure elements in the cryo-EM map and the pseudo-
atomic models, and also consistent with our previous results of 3D cryo-EM
RyR-GFP mapping and FRET measurement between RyR and FKBP. A com-
bined model of the RyR fragment and FKBP docked into the cryo-EM map
suggests that the fragment is positioned adjacent to the FKBP binding site. Its
predicted binding interface with FKBP consists of primarily electrostatic con-
tacts and contains several disease-associated mutations. A dynamic interaction
between the fragment and a RyR phosphorylation domain, characterized using
FRET data, also support the structural predictions of the pseudo-atomic models.
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Ryanodine receptors (RyRs) are large Ca2þ-release channels located in the SR
membrane. They play a central role in the excitation-contraction coupling of
skeletal (RyR1) and cardiac (RyR2) muscle. Over 500 disease mutations
have been identified in RyRs that can cause several skeletal muscle disorders
and cardiac arrhythmias. RyRs are also the target for phosphorylation, most
notably by CaMKII and PKA. Although a lot of controversy surrounds these
events, several studies indicate that phosphorylation can upregulate RyR
activity. Here we present crystal structures of a domain in all three different
RyR isoforms, containing the Ser2843 (RyR1) and Ser2808/Ser2814 (RyR2)
phosphorylation sites. There are 11 disease mutations located in the RyR1
domain, several of which cluster near the phosphorylation site, suggesting
that phosphorylation and disease mutations may affect the same interface.
Crystal structures of the disease mutants show that the mutations affect either
surface properties or intradomain salt bridges. One mutation, L2867G, causes
a drastic reduction of thermal stability of the domain, and results in aggregation
at room temperature. In vitro phosphorylation experiments identify several
novel PKA and CaMKII phosphorylation sites in the same loop region of the
RyR2 phosphorylation domain, also supported by another recent in vivo study.
The observation of simultaneous phosphorylation events on multiple sites
indicates that RyRs may be truly ‘hyperphosphorylated’. Docking into cryo-
electron microscopy maps locates the domain in the clamp region, a region
that has been shown to couple allosterically to channel opening. Disease muta-
tions and phosphorylation may therefore cause conformational changes that
affect the allosteric coupling and facilitate channel opening.
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Go¨ttingen, Germany.In super-resolution microscopy applications, previously unknown fluorescent
signal patterns are recorded. The interpretation of such nanoscale data is often
unexpectedly complex, and can be performed by different analysis strategies:
1) empirical statistics of the spatial distribution of intensity values to identify
local objects, 2) inverse problem approaches to convert signals into objects
based on external data models or other external assumptions, 3) decomposition
of spatial signal patterns into spatial modes.
Here, we compare and relate two distinct approaches of analysing STED
microscopy images of RyR2 clusters (cardiac ryanodine receptor type 2).
RyR2 Ca2þ release channels are essential for heart muscle function (excita-
tion-contraction coupling). Yet, the nature of lateral channel organization
within super-structural clusters is unknown and important for models of local
control mechanisms of RyR2 Ca2þ release activity.
We established multi-scale analysis of RyR2 signal patterns employing wavelet
analysis. This analysis decomposes the initial image with predefined wavelets
into spatial modes identifying dominant scales of signal fluctuations. We tested
the sensitivity of this approach for different wavelets with artificial and modi-
fied images. Distinct scales represent inter-cluster spacing and intra-cluster
patterns, respectively. Furthermore, we compare the spatial mode analysis
with object-based approaches. For object-based analysis, RyR2 cluster sub-
structures were identified with a multi-step thresholding procedure. After
increasing the threshold level step-by-step, the hierarchy of the segmentation
output was analysed with logical operators. Accordingly, we identified cluster
sub-structures as discrete objects of variable sizes with typical spacings ranging
from 78 to 128 nm (IQR range) that we interpret as individual cluster building-
blocks.
We conclude that identification of common protein cluster building principles
in highly variable signal structures as typical for RyR2 clusters benefits from
combining object-based approaches with spatial mode analysis.
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Many potassium channels use a conserved glycine residue to allow flexibility of
the inner helices and facilitate gating. A KcsA-based analogy model of the
RyR2 pore-forming region (Welch et al Biophys J 87: 2335-2351) indicates
that this region is composed of structural elements equivalent to those found
in potassium channels and includes a potentially equivalent inner-helix hinge
motif (GXXXXA).
We studied the functional consequences of substitutions of the conserved gly-
cine residue at position 4864 in recombinantly expressed human RyR2 GFP-
tagged proteins. Whilst wild type (WT) RyR2 and the mutants G4864A and
G4864V were expressed at equivalent levels in HEK293 cells, G4864P was
less tolerated with a reduced expression. This was confirmed by western blot
analysis in HEK293 membrane preparations.
Caffeine-induced intracellular calcium release was observed in Fluo3-loaded
HEK293 cells expressing WT, G4864A and G4864P RyR2 channels. In con-
trast cells expressing G4864V were not sensitive to caffeine. [3H]-ryanodine
binding to HEK293 membrane preparations resulted in similar specific binding
for WT and G4864A at 0.192 5 0.005 and 0.190 5 0.002 pmol/mg, while
G4864V and G4864P showed comparable low values of 0.006 5 0.001 and
0.002 5 0.002 pmol/mg, respectively. Characteristic single channel current
fluctuations were observed following the incorporation of purified WT and
G4864A RyR2 proteins into planar phospholipid bilayers and G4864A
channels displayed ion handling, and calcium-dependent gating properties
comparable to WT channels. No equivalent activity was observed for
G4864V and G4864P.
Our investigation indicates that whilst functionally sensitive to mutagenesis,
a glycine residue at 4864 is not essential for RyR2 channel gating. Rather, there
is a requirement for amino acids with small side chains that allow close packing
of helices during transitions from closed to open states. The BHF supported this
research.
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The ryanodine receptor (RyR) and dihydropyridine receptor (DHPR) along
with several other smaller proteins form a large and dynamic complex, often
referred to as the excitation-contraction coupling machinery. Complexes of
